If you could vote on Brexit now which option would you choose?

Can China’s home-grown mRNA Covid-19 vaccine pass its final tests?

China has moved a step closer to developing a home-grown mRNA vaccine against Covid-19, with the publication of early trial results for its prime candidate ARCoV. No serious adverse events were recorded in the phase 1 clinical trial data, published last week by The Lancet Microbe, but scientists said it was too early to judge its success. Large-scale trials of the vaccine – jointly developed by the Academy of Military Science, Walvax Biotechnology and Suzhou Abogen Biosciences – have been delayed since last year. No reason was given by the company, though it has become generally more difficult to recruit unvaccinated volunteers for phase 3 trials.

South China Morning Post - February 3, 2022

View the full story here: https://www.scmp.com/news/china/science/article/3165712/can-chinas-home-grown-mrna-covid-19-vaccine-pass-its-final-tests